Serum miR-26a-5p and miR-199b-5p as a biomarker to predict therapy for Diffuse Large B-cell lymphoma with Hepatitis C Infection

ASSESSMENT OF CIRCULATING CELL FREE DNA IN EGYPTIAN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Study of high mobility group box 1 protein level in patients with diffuse large b cell lymphoma

Clinical Impact of Hepatitis C Virus in Patients with B-Cell Non-Hodgkin Lymphoma

Clinical significance of LncRNA-MIAT as a non-invasive diagnostic marker of non-Hodgkin's lymphoma associated with occult hepatitis C virus infection

Evaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy